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Abstract 
Objectives: This meta-analysis aimed to 1) quantitatively synthesise evidence of factors 
related to the Quality of Life (QoL) of family carers of people with dementia (PwD); and 2) 
explore moderating factors that may influence the strength of the relationship between such 
potential predictive factors and carer QoL. 
Methods: Studies that investigated correlations between patient/carer-factors and QoL in 
unpaid family carers of PwD and were published in English, Spanish, Portuguese or Japanese 
were included. 
Results: Thirty-three studies were identified. The pooled correlations with carer QoL (effect 
size) were significantly large for depression (-0.58), significantly moderate for subjective 
burden (-0.47) and significantly small for PwD’s neuropsychiatric symptoms (-0.24). These 
results indicated to be robust in the context of publication bias. The results of subgroup 
analyses demonstrated the social and economic development status of the country where 
study participants resided did not moderate these effects. 
Conclusion: Carer depression, subjective burden and people with dementia’s 
neuropsychiatric symptoms may play a critical role in maintaining QoL of family carers 
regardless of the social and economic circumstances.  
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Introduction 
 The number of people living with dementia worldwide is currently estimated at 35.6 
million and this number is expected to double by 2030 and more than triple by 20501. 
Dementia is one of the most expensive health conditions and the current annual worldwide 
cost of dementia is estimated to be US$ 818 billion2. As such, dementia is considered as one 
of the greatest health challenges we face today. 
Dementia is a progressive condition and while some individuals maintain their 
independence for many years, many require progressively more support with daily activities, 
particularly in the later stage of the condition3. Family members are considered as a primary 
resource for this type of care in many countries. For example, in the UK, people affected by 
dementia and their relatives are currently shouldering two-thirds of all dementia care costs, 
saving the UK economy billions each year4. In Latin-American countries, such as Brazil, 
there are fewer healthcare services specialised in dementia, which reinforces the belief that 
families should be responsible for the person with dementia5. The lack of provision of 
dementia services within the public healthcare system is also common in Asian countries such 
as China, and as a consequence, families take over the significant caring role6. 
These suggest that unpaid family carers are an essential taskforce in caring for people 
with dementia worldwide. Therefore, this review focused on unpaid family carers (i.e. 
informal carers) who are characteristically different from formal carers (i.e., healthcare 
professionals) paid to provide essential care. 
Caring for someone with dementia can be physically and emotionally demanding and 
it can seriously affect the social, psychological and physical wellbeing of the family carer7, 8. 
The previous literature demonstrates that poor carer quality of life (QoL) is likely to be 
associated with poorer QoL for the person with dementia9 and with higher economic costs10. 
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QoL is a term frequently used in the literature but, to date, there is no consensus about 
how to best define and assess QoL in family carers of people with dementia11, 12. The World 
Health Organization (WHO) defines it as the individual's perception of their position in life in 
relation to their goals, expectations, standards and concerns, according to the culture and 
value systems in which they live. General QoL includes several aspects such as psychological 
state, physical health, level of independence, personal beliefs and spirituality, social 
relationships and environment13.  There is another important concept of QoL often used in the 
literature that is the Health-Related Quality of Life (HRQoL). HRQoL refers to the 
components of QoL that are directly and indirectly affected by health, disease, disorder, and 
injury and therefore, HRQoL often overlaps with the concept of health status14, 15. 
In the past ten years, there have been emerging studies which have developed more 
specific instruments to measure carer QoL11, 16, 17. Early carer studies predominately used 
general QoL and HRQoL measures. The use of general QoL and HRQoL instruments with 
older carers can be problematic as some aspects of these types of QoL (e.g., level of 
independence) could be affected by their age-related factors such as changes in physical 
conditions18. In this regard, these types of instruments have been criticised for lacking validity 
and not being sensitive enough to measure the psychological consequences and positive 
aspects of caring11, 19. In this meta-analysis, we defined the QoL of carers in a broader sense 
and included all types of QoL measures to provide a wider understanding of the potential 
impacts of different factors on carer QoL. 
The national guidelines and policies such as the United Kingdom Government’s action 
plan20 emphasise the need for focusing on early interventions for carers to support them 
maintaining their QoL. For this reason, it is fundamental to identify the modifiable factors that 
may affect the family carers’ QoL in order to guide the formulation and delivery of policy, 
treatment, care, and support to improve this crucial outcome21. 
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Previously, there have been three review studies that have examined factors associated 
with the QoL of family carers of people with dementia. The first systematic review 
conducted by de Oliveira, Vass & Aubeeluck, which solely focused on examining the 
association of carers’ advanced age with their QoL, demonstrated that carer’s advanced age to 
be associated with low levels of their QoL22.   
The second study, an integrative review conducted by Pereira & Soares and published 
in Portuguese, found that both factors related to carers themselves (e.g., having depression, 
poor sleep quality, pre-existing health problems, social support received, leisure activities, 
having received interventions or training for carers) and people with dementia (e.g., dementia 
type, neuropsychiatric symptoms) can influence the QoL of family carers23. 
The most recent systematic review conducted by Farina et al. found that having better 
physical and mental health was the factor most strongly associated with having a better QoL. 
They also found that greater carer independence (e.g. activities and time not spent on caring 
duties) was positively associated with better QoL and that carers who lived with the care 
recipient had poorer QoL than those who did not. The health status of the people with 
dementia and their behavioural and psychological symptoms also seem to be detrimental to 
carer QoL21.   
These three reviews highlighted that both carer- and patient-characteristics could be 
potential predictors of carer QoL. However, these reviews have some methodological 
limitations. First, all reviews only included studies written in English which might have 
induced a bias in the findings. One of the reviews22 only included studies that targeted carers 
aged 60 years or older and all included studies were carried out in developed countries and 
thus, the generalisability of the findings may be limited due to selection bias. When 
comparing the distribution of the total costs of dementia worldwide, 87% is currently spent in 
high-income countries despite the fact that the contribution of informal carers is expected to 
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be greatest in developing countries2. It is, therefore, important to explore the impact of 
dementia across countries with different economic development status. Another limitation is 
that the second review by Pereira & Soares did not employ a systematic approach, but it was 
rather an integrative review using purposive sampling. Therefore, the findings could be prone 
to researcher bias23. 
Large heterogeneity in the study designs was also evident across all three reviews. The 
authors combined correlational and regression studies21-23 and included interventional and 
cross-sectional studies23 or quantitative and qualitative studies21 in their single purposive 
sampling review. As a result, the included studies were completely heterogeneous, making it 
difficult to draw a robust conclusion.   
Moreover, although the most recent review by Farina et al. was published in 2017, the 
literature search was conducted in November 2015. Taking into consideration that in recent 
years, there has been an increasing interest in dementia care research24, it is expected to find a 
larger number of articles over the last few years. As such, an updated review could address 
previous limitations and enhance our understanding of factors associated with carer QoL. 
To overcome the aforementioned limitations and clarify the current state of the 
evidence base, an updated review using a meta-analytic approach was conducted with the 
following objectives: 
1) To quantify the point estimate of effect size between carer QoL and different types of 
independent variables including those related to carers themselves (e.g., carer depression) and 
people with dementia (e.g., neuropsychiatric symptoms); and  
2) To explore factors that may moderate the strength of such relationship including the 
development status of the country and types of tools used to assess the constructs of interest. 
Methods 
7 
 
 
 
This meta-analysis adhered to the Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses guidelines 25. The PRISMA checklist is included as a supplementary file 
(see Supplementary Table 1). 
Eligibility Criteria 
The review included quantitative articles published in peer-reviewed journals or 
academic reports (e.g. PhD thesis). Only cross-sectional and longitudinal studies were eligible 
for the review. 
In order to be eligible for the current review, the study had to (a) recruit unpaid family 
carers of people with dementia; (b) use a validated measure of generic, health-related or care-
related QoL to assess QoL in family carers as a dependent variable; (c) be published in 
English, Spanish, Portuguese or Japanese; and (d) report a Pearson correlation between the 
dependent variable (i.e., carer QoL) and independent variables. Any types of independent 
variables were eligible for the review including variables related to carers themselves (e.g., 
carer depression) and people with dementia (e.g., neuropsychiatric symptoms). 
Information Sources 
The databases of PubMed, PsycINFO and Scopus were searched to identify relevant 
published articles. ProQuest was used to search unpublished doctoral thesis and Lilacs and 
Scielo were used to search for studies from Spain and Latin America.  
Search 
The search was conducted by the first author (MC) using the keywords and search 
strategies outlined in Supplementary Table 2. Manual searches in the reference lists of 
relevant systematic reviews and articles were also completed to identify any potential missing 
articles. No date restriction was applied to the search for studies. 
Study Selection 
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Search results were merged using EndNote software and duplicate articles were 
removed. All the titles and abstracts were screened for eligibility by the first author (MC), 
whereby clearly irrelevant articles were excluded. Following the initial screening, full-text 
articles were reviewed by two authors (MC and NK) independently using a structured 
checklist. The Kappa coefficient for the inter-rater agreement was .84, indicating almost 
perfect agreement26. Disagreements between two coders were resolved through discussions. 
Data Collection Process 
The first author (MC) developed an electronic data extraction sheet, which was pilot 
tested on a randomly selected study by two authors (MC and NK). Following this, the 
electronic form was refined accordingly. To minimize bias, data extraction was conducted on 
the first five selected studies by two authors (MC and NK) independently. No discrepancies 
were identified during this pilot phase. Following this, the first author (MC) and a research 
assistant independently extracted data from the remaining studies. The agreement rate 
between the two coders was 90.3%, indicating almost perfect agreement. 
Data Items 
For each included study, information was recorded on (a) study characteristics (the 
country where the study was conducted and study design); (b) sample characteristics (number 
of participants, age, gender, relationship with the person with dementia, the average length 
being a carer); (c) dementia type of the carer recipient; (d) measures used to assess carer QoL; 
(e) measures used to assess independent variables; and (f) correlation coefficient between 
carer QoL and the independent variables. If relevant information was not provided in the 
selected studies, it was considered as “not reported” and the authors did not contact 
researchers for further clarification. 
Risk of Bias in Individual Studies 
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The Appraisal of Cross-sectional Studies27 was used to assess the risk of bias in each 
included study. This tool consists of 20 items which assess different aspects of the 
methodological quality and reporting quality such as appropriateness of study design and 
target population, measurement validity and reliability, appropriateness of interpretation of 
results and justification of conclusion. The Appraisal of Cross-sectional Studies does not 
include a numerical scale that can be used to produce a quality assessment score; instead, it 
aims to measure the individual characteristics of a study cumulatively28. The first author and a 
research assistant assessed the risk of bias independently and disagreements were discussed. 
The Kappa coefficient for the inter-rater agreement was 0.56 indicating moderate agreement 
between the raters26. 
Summary of Measures and Synthesis of Results 
The entire analysis was conducted using Comprehensive Meta-Analysis software 
version 329.  There are no simple criteria in terms of how many studies are needed to calculate 
the meaningful pooled effect size. However, the combination of very few studies with very 
different characteristics makes any kind of synthesis untenable in most cases30. In this study, 
the meta-analysis was conducted only when the correlation coefficient between carer QoL and 
the targeted independent variable was available from more than three studies (i.e., if only two 
studies reported the correlation coefficient between carer QoL and the targeted independent 
variable and then quantitative synthesis was not performed). 
The correlation coefficient from included studies was transformed to corresponding 
Fisher’s scores to estimate a pooled effect size and its 95% confidence intervals (CI) for each 
independent variable. A fixed-effect model was used to provide a pooled estimated effect for 
each independent variable and a test for heterogeneity was performed using the Q-statistic and 
the I2 statistic. Where there was evidence of heterogeneity a random-effects model was used. 
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Estimated effect sizes of <0.09 were considered negligible, 0.10–0.29 small, 0.30–0.49 
moderate and >0.50 large31. 
If the correlation coefficient for the same independent variable was reported from two 
or more independent samples within a single study, they were treated as separate studies for 
the purpose of analyses. For example, the correlation coefficient for the same independent 
variable was reported separately for female and male samples in one study32 and for carers of 
people with mild, moderate and severe dementia in another study33. When the correlation 
coefficient for the same independent variable was reported for each subscale of the QoL 
measure rather the total QoL score within a single study34, correlation coefficients were 
combined by calculating the mean of effect sizes across subscales to produce a single effect 
size35. The “total QoL score” was used when possible36. 
Risk of Bias Across Studies 
To assess publication bias, the trim and fill method37 was used to estimate how many 
studies could be missing from each meta-analysis and calculate adjusted effect-size estimates. 
Rosenthal’s Fail-Safe N38 was used to calculate the number of missing studies needed to be 
included in the analysis to reduce the overall effect size to a non-significant level. If only a 
few studies are required to nullify the observed effect, the observed overall effect may not be 
robust35. 
Additional Analyses 
For those independent variables, which demonstrated a significant heterogeneity, a 
series of subgroup analyses were planned to examine the possible sources of variance. 
Initially, a series of subgroup analysis using the following moderators were planned: (a) the 
development status of the country as defined by the Human Development Index (HDI) 
category (low, medium, high, very high), which is a summary measure of a country’s overall 
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achievement in its social and economic dimensions (i.e., health, education and standard 
living)39; (b) types of measures used to assess carer QoL; (c) types of measures used to assess 
the independent variable; (d) the relationship with the person with dementia; (e) dementia 
type of the care recipient; (f) carer’s gender; and (g) average length being a carer. However, 
the latter four moderators (i.e., relationship, dementia type, gender, length as a carer) were not 
reported consistently in many of the included studies or seemed to be similar across the 
included studies that did report. Therefore, it was not possible to conduct the subgroup 
analyses using these four moderators.  
Results 
Study Selection 
The search was conducted on 30th May 2018 and a total of 2458 articles were found. 
After deleting 1124 duplicated articles, 1334 titles and abstracts were examined by the first 
author (MC). One hundred and two studies were identified as relevant for the meta-analysis 
and the full text were reviewed by the two coders (MC and NK) independently. From the 102 
full-text reviewed, 33 fulfilled the inclusion criteria and data was extracted from each study. 
However, only 27 were included in the final meta-analysis (See Figure 1). The remaining five 
studies did report correlations between QoL and some independent variables, but data for the 
same independent variable was not available from more than three studies. Thus, these five 
studies were not included in the quantitative synthesis. 
Study Characteristics 
Participants. The characteristics of included studies are presented in Table 1. The 
total number of carers was 6177. The majority of studies recruited carers from Europe (study 
n=12), North America (n=8) and South America (n=8). There were fewer studies which 
recruited carers from Asia (n=4) and Oceania (n=1). More than 65% of carers were females in 
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the majority (over 70%) of the studies included (n=24). Over 75% of the studies (n=26) 
recruited people over 55 years old and 78% of studies only recruited carers with Alzheimer’s 
disease (n=26). This diagnosis was the most prevalent in the remaining studies. Eight studies 
did not report the type of dementia of the care recipient. These results suggest that carers 
recruited in the identified studies were predominantly females over 55 years old looking after 
a family member with Alzheimer’s disease. 
QoL measures. The most commonly used measure of carer QoL were Quality of Life 
in Alzheimer’s disease for carers40 (QoL-AD; n=7), 36-Item Short Form Survey41 (SF-36; 
n=6) and WHO-QOL-BREF13 (n=6).  Over 60% of the included studies (n=20) used a general 
QoL measure (e.g., QoL-AD, WHO-QOL-BREF) and the rest used a health-related QoL 
measure (e.g., SF-36, EuroQol-5D42).  
Independent variables. Most of the included studies reported correlations between 
carer QoL and carer subjective burden (n=11), carer depression (n=10), people with 
dementia’s neuropsychiatric symptoms (n=11) and their level of independence in activities of 
daily living (ADL) (n=10). The majority of the studies used the Zarit Burden Interview 
(ZBI)43 to measure subjective burden (n=10), the Beck Depression Inventory (BDI)44 to 
measure depression (n=5), the Neuropsychiatric Inventory (NPI)45 to measure 
neuropsychiatric symptoms (n=6) and the Katz Index of Activities of Daily Living46 (n=3) to 
measure ADL.  
Independent variables that were not included in the meta-analysis due to the number 
of studies identified were carer anxiety, satisfaction with life, coping strategies, social skills, 
frequency of nocturnal disruptions, relationship quality with the person with dementia, 
interpersonal support, some personality traits such as extraversion and neuroticism, physical 
health, number of hours providing care weekly, duration of caregiving in years (see Table 1). 
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Risk of bias within studies 
The assessment of study quality and bias using the Appraisal of Cross-sectional 
Studies tool is presented in Table 2. All of the included studies clearly specified the aim of the 
study, used the appropriate study design, clearly defined the target population, measured carer 
QoL appropriately, used validated questionnaires, fully described the methods, and presented 
the results of all the analyses described in the methods. Overall, the methodological quality 
was adequate across the included studies. However, the majority of the included studies 
(n=25) did not justify the sample size and almost no studies reported information about non-
responders. 
Synthesis of results 
Twenty-seven studies included in the meta-analysis demonstrated associations 
between carer QoL and different types of carer-related independent variables (subjective 
burden, depression, age, income, and distress) and people with dementia-related independent 
variables (neuropsychiatric symptoms, ADL, cognitive functioning and self-/proxy-rated 
QoL). A random model was used for carer depression and subjective burden, people with 
dementia’s proxy-rated QoL, their neuropsychiatric symptoms and ADL due to significant 
heterogeneity.  
Independent variables with a significant effect size (Figure 2) 
Carer’s depression (number of studies included in the analysis n=10).  Ten studies 
reported the correlation coefficient between carer QoL and depression. The effect sizes varied 
from -0.30 to -0.82. Overall, the point estimate of effect size between carer QoL and 
depression was -0.58 (95% CI = -0.66 - -0.48, p < 0.00) suggesting a significant large effect. 
There was statistically significant high heterogeneity between study effect sizes (I2 = 80.77%, 
Q = 57.29).  
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Carer’s subjective burden (n=11). The effect sizes varied from -0.03 to -0.66. The 
point estimate of effect size between carer QoL and subjective burden was -0.47 (95% CI = -
0.51 - -0.21, p < 0.00), suggesting a significant moderate effect. The heterogeneity between 
study effect sizes was significantly high (I2 = 87.95%, Q = 82.98).  
Carer’s distress (n=3). The effect sizes varied from -0.15 to -0.34. The point estimate 
of effect size between carer QoL and care’s distress was small -0.22 (95% CI = -0.33 - -0.11, 
p < 0.00). The heterogeneity between study effect sizes was not significant (I2 = 0.00%, Q = 
1.94). However, this could be due to the limited number of studies included. 
People with dementia’s self-rated QoL (n=3). The effect sizes varied from 0.25 to 
0.55.  The point estimate of effect size between carer QoL and self-rated QoL was 0.37 (95% 
CI = 0.24 - 0.49, p < 0.00) suggesting a significant moderate effect. The heterogeneity 
between study effect sizes was not statistically significant (I2 = 41.07%, Q = 5.09).  
People with dementias proxy-rated QoL (n=5). The effect sizes varied from -0.15 to 
0.44.  The point estimate of effect size between carer QoL and proxy-rated QoL was 0.27 
(95% CI = -0.00 - 0.51, p < 0.05) suggesting a significant small effect. The heterogeneity 
between study effect sizes was significantly high (I2 = 89.69%, Q =38.79).  
People with dementia’s neuropsychiatric symptoms (n=11). The effect sizes varied 
from -0.11 to -0.44. The point estimate of effect size between carer QoL and neuropsychiatric 
symptoms was -0.24 (95% CI = -0.31 - -0.17, p < 0.00) suggesting a significant small effect. 
There was statistically significant moderate heterogeneity between study effect sizes (I2 = 
61.77%, Q = 28.73). 
Independent variables with no significant effect size (Supplementary Figure 1) 
Carer’s income (n=4). The effect sizes varied from -0.06 to 0.30. The point estimate 
of effect size between carer QoL and care’s income was 0.13 (95% CI = -0.00 - 0.26, p 
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=0.06). Both the overall effect size and the heterogeneity between study effect sizes were not 
statistically significant (I2 = 42.23%, Q = 5.19). 
Carer’s age (n=10). The effect sizes varied from -0.10 to 0.10. Overall, the point 
estimate of effect size between carer QoL and carer’s age was -0.03 (95% CI = -0.05 - 0.0, p 
= 0.13). Both the overall effect size and the heterogeneity between study effect sizes were not 
statistically significant (I2 = 0.00%, Q = 2.58). 
People with dementia’s cognitive functioning (n=8). The effect sizes varied from -
0.15 to 0.29. The point estimate of effect size between carer QoL and cognitive functioning 
was -0.04 (95% CI = -0.05 - 0.13, p = 0.40). Both the overall effect size and the heterogeneity 
between study effect sizes were not statistically significant (I2 = 44.83%, Q = 14.50). 
People with dementia’s ADL (n=10). The effect sizes varied from -0.33 to 0.17. The 
point estimate of effect size between carer QoL and ADL was -0.01 (95% CI = -0.07 - 0.8, p 
= 0.79). Both the overall effect size and the heterogeneity between study effect sizes were not 
statistically significant (I2 = 53.20%, Q = 21.37). 
Risk of Bias Across Studies 
 The Duval & Tweedie trim-and-fill approach suggested that potentially no studies are 
missing for carer’s depression, distress, income and age as well as people with dementia’s 
neuropsychiatric symptoms and ADL. The results demonstrated that six studies are potentially 
missing for carer’s subjective burden and three for people with dementia’s cognitive 
functioning. If these missing studies were imputed, the point of estimate would decrease to -
0.58 (95% CI = -0.69, -0.44) and -0.01 (95% CI = -0.07, 0.05) respectively. The results 
demonstrated that one study is potentially missing for people with dementia’s self-rated and 
proxy-rated QoL. If these studies are imputed, the point of estimate would decrease to 0.30 
(95% CI = 0.18, 0.41) and 0.23 (95% CI = -0.01, 0.44) respectively. 
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Rosenthal’s Fail-safe N analysis suggested that more than 100 studies are required for 
the combined two-tailed p-value to exceed .05 for depression, subjective burden and people 
with dementia’s neuropsychiatric symptoms, suggesting that the observed point of estimates 
are likely to be robust for these independent variables. Rosenthal’s Fail-safe N analysis 
suggested that less than 50 studies are required for carer’s distress people with dementia’s 
self-rated QoL and proxy-rated QoL suggesting that the observed point of estimates are less 
likely to be robust for these two variables. 
Subgroup Analyses 
Subgroup analyses were conducted with independent variables which demonstrated a 
significant heterogeneity (i.e., people with dementia’s neuropsychiatric symptoms, their 
proxy-rated QoL, carer’s depression and carer’s subjective burden). The possible sources of 
variance were tested using three moderators (i.e., the development status of the country, types 
of measures used to assess carer QoL and types of measures used to assess the independent 
variable). 
 People with dementia’s neuropsychiatric symptoms. Subgroup analyses 
demonstrated that the point of estimate for neuropsychiatric symptoms differed according to 
the type of measure used to assess neuropsychiatric symptoms (p<0.01), but not according to 
the development status of the country (p=0.79) or the type of measures used to assess carer QoL 
(p=0.47). The subgroup of studies that used Revised Memory and Behaviour Problems 
Checklist (RMBPC)47 reported the lowest effect estimate while the study that used the 
Baumgarten Dementia Behaviour Disturbance questionnaire (DBD)48 reported the highest 
estimate of effect. 
People with dementia’s proxy-rated QoL. Subgroup analyses demonstrated that the 
point of estimate for people with dementia’s proxy-rated QoL differed according to the type of 
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measure used to assess their QoL (p<.01) and the types of measures used to assess carer QoL 
(p<0.01) but not according to the development status of the country (p=0.48). The subgroup of 
studies that used EQ-5D to assess proxy-rated QoL as an independent variable reported the 
lowest effect estimate while the studies that used proxy-rated QoL-AD reported the highest 
estimate of effect. The subgroup of studies that used EQ-5D to assess carer QoL as a dependent 
variable reported the lowest effect estimate while the studies that used SF-12 reported the 
highest estimate of effect. 
Carer’s depression. The test for subgroup differences indicated that the point of 
estimate for carer’s depression did not differ according to any of moderators (measures used to 
assess depression p=0.72; measures used to assess carer QoL p=0.94; development status of the 
country p=0.69). 
Carer’s subjective burden. Subgroup analyses demonstrated that the point of estimate 
for carer’s subjective burden did not differ according to any of moderators (measures used to 
assess subjective burden p=0.68; measures used to assess carer QoL p=4.00; development status 
of the country p=0.48).  
 
Discussion 
The current meta-analysis had two purposes, mainly to quantify the point estimate of 
effect size between carer QoL and different types of independent variables related to carers 
themselves and people with dementia. Secondly, it aimed to explore factors that may 
moderate the strength of such relationships, including the development status of the country 
and types of tools used to assess the measures of interest. To our knowledge, this was the first 
meta-analysis to quantitatively synthesise the factors associated with carer QoL. Thirty-three 
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cross-sectional studies providing data from 6177 family carers were included, however, only 
27 studies were included in the final meta-analysis.  
The current meta-analysis found that the pooled correlations with carer QoL (i.e., 
effect size) were significantly large for depression and significantly moderate for carer 
subjective burden, while the effect size for people with dementia’s neuropsychiatric 
symptoms was significant but small. These results were indicated to be robust in the context 
of publication bias. The effect size for people with dementia’s self-rated QoL was also 
significantly moderate. Furthermore, the effect size was significantly small for people with 
dementia’s proxy-rated QoL and carer’s distress. However, these results were less likely to be 
robust in the context of publication bias, therefore, the findings need to be interpreted with 
caution.  
The results of this meta-analysis support evidence from the previous review21 that 
suggested that carer’s mental health and people with dementia’s behavioural and 
psychological symptoms were strongly associated with carer QoL. On the other hand, the 
findings differed from those of de Oliveira, Vass & Aubeeluck, which included only studies 
that targeted carers aged 60 and over 22. While the previous review suggested that carer’s 
increased age was associated with lower levels of QoL, the results of the current meta-
analysis without any age restriction did not support this association. This could be due to the 
differences in methodological approaches. De Oliveira, Vass & Aubeeluck included both 
regression and correlational studies in the systematic review and did not conduct a 
quantitative synthesis22. The current study also included four studies that were not considered 
in the review conducted by de Oliveira, Vass & Aubeeluck and the findings of the current 
study were similar to those from a more recent review conducted by Farina et al., which 
concluded that the associations between carer QOL and carer age to be less clear21. 
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The results of subgroup analyses demonstrated the moderating effect of the country 
development status (i.e., high versus very high developed countries) was not significant for 
any of the independent variables. The results of subgroup analyses suggest that independent 
variables which are considered to be a critical predictor of carer QoL (i.e., carer depression, 
carer subjective burden and neuropsychiatric symptoms) may be important variables for 
intervention regardless of the opportunities offered for better health, education and living 
conditions across different high and very high developed countries.  
This finding is particularly important as, in the recent years, there has been an increase 
in the number of interventions developed for family carers of people with dementia, but the 
majority of well-established interventions have only been tested in the most economically 
developed countries49, 50. Interventions that can be accessed globally and can support carers 
worldwide are urgently needed considering that a greater number of people with dementia are 
currently living in low and middle-income countries and this trend is expected to be more 
profound in the future51. 
The well-established multi-component interventions that can tackle some of the 
critical predictors such as START52 could be beneficial for carers from countries with the 
lower development status if the intervention materials could be translated into multiple 
languages. However, there are other factors that should be considered apart from the language 
translation such as differences in culture, health and social care systems and the availability of 
resources including skilled therapists. To address such challenges, the 10/66 Dementia 
Research Group developed a programme called Helping Carers to Care, which is a 
psychoeducational intervention especially designed for use in low and middle-income 
countries and this programme has already been tested in India, Peru and Russia53. 
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The results of subgroup analyses also demonstrated that the type of measure used to 
assess independent variables such as neuropsychiatric symptoms and people with dementia’s 
proxy-rated QoL may moderate the relationship between these variables and carer QoL. It is 
not possible to make direct recommendations on which measures to be used to assess these 
types of variables based on the current review due to a large variability across included 
studies. The future studies are required to carefully make a choice of measures guided by 
several considerations such as the setting in which the assessment will occur and their 
reliability and validity. For example, previous studies have found that the Neuropsychiatric 
Inventory (NPI) seems to be one of the most efficient measures of people with dementia’s 
neuropsychiatric symptoms, as it includes multiple behavioural domains at a general level as 
well as targets specific behaviours within domains and can be used in multiple clinical 
settings54. A recent systematic review, which identified 16 different types of QoL measures 
specifically designed for people with dementia, concluded that many measures still have 
limited evidence supporting their reliability and validity and thus more research is needed to 
have complete confidence in their utility55. 
Limitations 
 This meta-analysis has some methodological limitations. Firstly, although we made 
every effort to minimise missing studies, all the identified studies were from high or very high 
developed countries as indicated by the HDI category. Regardless of the inclusion of non-
English articles, the current meta-analysis was not able to identify any studies from low 
developed countries (e.g., countries from Africa, Central America, Caribbean islands and 
some areas of Asia).  However, it is worth mentioning that the current meta-analysis included 
seven studies conducted in countries that are defined as high developed countries by the HDI 
(e.g., Colombia and Brazil), but are also considered middle-income countries according to the 
World Bank classification by income per capita56. Thus, the results of the subgroup analysis 
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by the HDI category still provide an important implication. Although, it is recommended 
future cross-sectional studies focus on researching the impact of caring on carer QoL in low 
developed countries as a great number of people with dementia are expected to be living in 
these countries57.  
Secondly, due to a large variation in the existing assessment tools, it was not possible 
to have enough studies in each subcategory when conducting subgroup analyses for some 
independent variables such as people with dementia’s proxy-rated QoL and their 
neuropsychiatric symptoms. For example, 11 studies with four different types of measures 
were included in the analysis of neuropsychiatric symptoms. Of these 11 studies, there was 
only one study that used the DBD. Consequently, these results could potentially change if 
more studies are included. 
Furthermore, subgroup analyses were also challenging as characteristics of the sample 
(e.g., relationship with the person with dementia, hours of caring per day) were not fully 
reported across the included studies. Therefore, only three moderating factors were explored 
in the current study.  In order to conduct a robust moderation analysis, we encourage future 
cross-sectional studies to fully report data on sample characteristics for both carers and people 
with dementia.  
 Thirdly, similarly to previous reviews21-23, all included studies employed a generic 
QoL or HRQoL measures to assess carer QoL and no studies used care-related QoL measures. 
This is problematic as generic measures of QoL may not capture caring-specific components 
that can affect QoL and might not be sensitive enough for detecting changes in the 
progression of dementia21, 58, 59. Therefore, it is recommended that future studies use carer-
related QoL instruments. 
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  Fourthly, some independent variables that reported a statistically significant 
correlation with carer QoL were not included in the meta-analysis due to the small number of 
studies identified (i.e., fewer than three studies). These independent variables included carer 
anxiety, satisfaction with life, coping strategies, social skills, frequency of nocturnal 
disruptions, relationship quality with the person with dementia, interpersonal support, some 
personality traits such as extraversion and neuroticism, physical health, number of hours 
providing care weekly, and duration of caregiving in years. Future studies should continue 
exploring the association of carer QoL with these variables in order to be included in future 
meta-analyses, especially with anxiety as the correlation was reported to be strong in two 
studies60, 61. A recent systematic review also highlighted that although anxiety is a prevalent 
psychological difficulty experienced by family carers of people with dementia, it is somewhat 
neglected compared to other carer outcomes (e.g., care burden, depression) in the current 
literature and therefore requires more attention62. 
Previous studies also have demonstrated that carer’s race and ethnicity can have an 
impact on carer outcomes such as depression and burden63-65. Ethnicity was not included in 
the current meta-analysis as in most of the included studies the data was collected mainly 
from white carers and there was a lack of diversity in the study samples. Future cross-
sectional studies should look at other ethnicities and races to understand how it might affect 
the caring experience.  
Finally, the current meta-analysis was based on correlational studies, and thus the 
causality in the relationship between independent and dependent variables may not be entirely 
one-way. It is possible that poorer carer QoL could lead to higher depression or worse 
neuropsychiatric symptoms. Future longitudinal studies should explore how these variables 
change over time as dementia progresses. 
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Conclusion and Implications 
 In summary, this meta-analysis revealed that carer depression, carer subjective burden 
and people with dementia’s neuropsychiatric symptoms are critical predictors of carer QoL. 
Therefore, carer interventions that can target multiple outcomes, such as these three variables, 
seem important for improving carer QoL. Most of the included participants were female, over 
fifty-five years old and from developed countries, thus the findings may not be able to 
generalise to the groups of carers who do not fall into this category. 
It is highly recommended for future studies to target a wider population, including 
those from low or moderately developed countries, to use instruments specifically designed 
for carers to measure carer QoL and to explore the relationship between carer QoL and those 
independent variables that seem to have a strong correlation with carer QoL but have been 
less studied such as carer anxiety. 
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Figure 1: PRISMA flowchart of the selection of studies. 
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Table 1: Characteristics of included studies. 
Authors Country Sample Relationship to patient (%) 
Average 
length being 
carer in years 
Care Recipient 
Characteristics 
(Diagnosis, 
severity %) 
Carer QoL 
measures Variables correlated with QoL 
1. 
Andreakou 
(2016) 
Greece 
155 carers Spouse: 38.00 
4.6 
Diagnosis: 
Alzheimer's  
SF-36 (mental and 
physical 
components) 
Depression (ZDRS) 
Female %: NR Daughter/son: 48.40 Mild: 22.6  
Mean age (SD): 58.1 
(13.4) Sibilings: 2.60 Moderate: 54.8 
 
 Other: 11.60 Severe: 22.6  
2. Araujo de 
Amorim 
(2017) 
Brazil 
41 carers Spouse: 34.10 
4.8 
Diagnosis: 
Alzheimer's  
WHOQOL-BREF 
Social Skills 
Female %: 87.8 Daughter/son: 56.09 Severity: NR  
Mean age (SD): 61.09 
(13.4) Other: 9.81 
  
3. Borghi 
(2011) Brazil 
50 carers Spouse: 16.00 
4.63 
Diagnosis: 
Alzheimer's  
QoL-AD 
Carer-rated PwD QoL (QoL-AD) 
Female %: 82.0 Daughter: 60.0 Severity: NR  
Mean age (SD): 53.83 
(14.52) Other: 24.00 
  
4. Coen 
(1999) Ireland 
50 carers Spouse: 46.00 
2  (Median) 
Diagnosis: 
Alzheimer's  
Evaluation of 
Individual Quality 
of Life – Direct 
Weighting 
(SEIQoL-DW) 
Perceived Burden (ZBI); Well-being; Social support; 
Behaviour disturbance (DBD); Cognitive functioning; 
Functional status; Carer-rated patient QoL (QoL-AD) 
Female %: 72.0 Daughter/son: 44.00 Mild: 66.0 
Mean age: 56.5 Sibilings: 2.00 Moderate: 22.0 
 Other: 8.00 Severe: 12.0 
5. Conde-
Sala (2010) Spain 
251 carers Spouse: 44.60 
NR 
Diagnosis: 
Alzheimer's  
SF-12 (mental 
component) 
Daughter-rated patient QoL (QoL-AD); Wives-rated 
patient QoL (QoL-AD); Husbands-rated patient QoL (QoL-
AD); Son-rated patient QoL (QoL-AD) 
Female %: 66.1 Daughter/son: 55.30 Mild: 10.36 
Mean age (SD): Spouse: 
75.3(7.3); Child: 79.5(5.7) 
 Moderate: 68.92 
 Severe: 20.72 
6. Creese 
(2008) Canada 
60 carers Spouse: 100 
4.61 
Diagnosis: 
Alzheimer's  SF-36 (mental and 
physical 
components) 
Current sleep quality; Change in sleep quality; Frequency of 
nocturnal disruptions; Current sleep quality; Change in sleep 
quality; Frequency of nocturnal disruptions 
Female %: 68  Severity: NR 
Mean age (SD): 73.65 
(9.26) 
  
7. Crellin 
(2015) UK 
289 carers Spouse: 63.3 
4.4 
Alzheimer's: 51.0 
SF-12 (mental and 
physical 
components) 
Positive impact; QoL physical component score (SF-12); 
Self-efficacy for obtaining respite; Self-efficacy for 
responding to disruptive behaviours; Self-efficacy for 
controlling upsetting thoughts; Self-efficacy for managing 
neuropsychiatric symptoms; Quality of support, Emotion-
focused coping; Problem focused coping; Dysfunctional 
coping; PwD neuropsychiatric symptoms (NPI); PwD 
Cognitive funtioning; PwD activities of daily living   
Female %: 68.2 Adult child/other family: 34.9  Vascular: 18.6 
Mean age (SD): 66.7 
(12.3) Other: 1.7 Others: 30.4 
  Mild: 63.0 
  Moderate: 27.0 
  Severe: 10.0 
   
Note:NR= Not reported; QoL= quality of life; PwD= people with dementia, AD= Alzheimer’s Disease. SF= Short form; ZDRS= Zung Depression Rating Scale; ZBI= Zarit Burden Interview; DBD= Dementia Behaviour Disturbance. Variables 
in bold are those ones that presented statistically significant correlations with carer QoL. 
Authors Country Sample Relationship to patient (%) 
Average 
length being 
carer in years 
Care Recipient 
Characteristics 
(Diagnosis, 
severity %) 
Carer QoL 
measures Variables correlated with QoL 
8. Feast 
(2017) UK 
157 carers Spouse: 53.55 
NR 
Diagnosis: NR 
EQ-5D 
BPSD-related distress; Frequency of BPSD; Relationship 
quality; Carer competence; Carer guilt; Carer-rated patient 
QoL (EQ-5D); Burden (The relative stress scale); Reactivity 
to BPSD 
Female %: 70.96  Severity: NR 
Mean age: 66.34   
9. Häusler 
(2016) Germany 
82 carers Spouse: 100 
NR 
Alzheimer's: 78.05 
WHOQOL-BREF Perceived Stress 
Female %: 60.97  Vascular: 18.6 
Mean age (SD): 73.02 
(6.68) 
 Lewy bodies:  
  Others: 30.4 
    Severity: NR 
10. Jackson 
(2009) UK 
132 carers Spouse: 36.00 
NR 
Diagnosis: 
Alzheimer's  WHOQOL-BREF 
Activities of Daily Living; Memory and Behaviour 
Problems (MBPC-1990R) 
Female %: 72.0 Offspring (or son  Severity: NR Physical 
Mean age (SD): 62 (13.4) or daughter in law) : 44.00  Psychological 
 Siblings: 4.00  Social 
  Other: 16.00   Environmental 
11. 
Kaufman 
(2010) 
United 
States 
141 carers Spouse: 9.9 
NR 
Diagnosis: NR 
Quality of Life 
Inventory (QOLI) 
Interpersonal Support tangible component; Interpersonal 
Support appraisal component; Interpersonal Support 
belonging component; Interpersonal Support self-esteem 
component 
Female %: 85.1 Daughter/son: 58.9 Severity: NR 
Mean age: 52 Other: 31.2  
12. kim 
(2016) 
South 
Korea 
476 carers Spouse: 67.7 
4.3 +/- 4.6 
Diagnosis: NR 
SF-36 (mental and 
physical 
components) 
QoL Mental component & Physical component (SF-36); 
Depression (BDI); Burden (ZBI) Extraversion; 
Agreeableness; Conscientiousness; Neuroticism, Openness 
Female %: 67.7 Daughter/son: 37.9 Severity: NR 
Mean age (SD): 57.4 
(13.1) Other: 42.5 
 
13. Kramer 
(1993) 
United 
States 
72 carers Spouse: 100 
4.75 
Diagnosis: 
Alzheimer's  
The Quality of Life 
Index 
PwD functional status ADL; PwD functional status 
instrumental ADL; PwD Memory and behavior problems 
(MBPC); Caregiver age; Duration of caregiving; Quality of 
prior relationship; Physical health; Family income; Social 
involvement satisfaction; Appraisal of the stressfulness of 
ADL; Appraisal of the stressfulness of IADL; Appraisal of 
the stressfulness of MBP 
Female %: 100.0  Severity: NR 
Mean age: 70.0   
   
14. 
Markowitz 
(2003) 
United 
States 
2477 carers Spouse: 67.7 
NR 
Diagnosis: 
Alzheimer's  
SF-12 (mental and 
physical 
components) 
PwD disruptive behaviour (MBPC-R); PwD feelings of 
depression (MBPC-R); PwD Memory (MBPC-R); PwD 
instrumental funtioning; PwD personal funtioning; No hours 
per week providing care; Caregiver's age 
Female %: 77.7 Daughter/son: 37.9 Severity: NR 
Mean age (SD): 58.8 
(10.1) Other: 42.5 
 
   
Note:NR= Not reported; QoL= quality of life; PwD= people with dementia. BPSD= Behavioural and psychological symptoms of dementia; MBPC= Memory and Behaviour Problems Checklist; SF= Short form; BDI= Bender Depression 
Inventory; ZBI= Zarit Burden Interview; ADL= Activities of daily living; IADL= Instrumental activities of daily living; MBPC-R= Memory and Behaviour Problems Checklist-revised. Variables in bold are those ones that presented statistically 
significant correlations with carer QoL. 
Authors Country Sample Relationship to patient (%) 
Average 
length being 
carer in years 
Care Recipient 
Characteristics 
(Diagnosis, 
severity %) 
Carer QoL 
measures Variables correlated with QoL 
15. 
McConaghy 
(2005) 
Australia 
42 carers Spouse: 54.76 
5.45 
Diagnosis: NR 
SF-12 v2 Physical 
component 
Coping; Burden (ZBI); Satisfaction with life 
Female %: 76.2 Daughter/son: 34.8 Mild: 40.9  
Mean age (SD): 62 (13.2) Other: 9.5 Moderate: 18.18  
    Severe: 40.9   
16. 
McLennon 
(2011) 
United 
States 
84 carers Spouse: 100 
4.6 
Diagnosis: NR 
SF-36 v2 (mental 
and physical 
components) 
Income; Duration of caregiving; Burden (ZBI); Finding 
meaning; Education;  
Female %: 59.5  Severity: NR 
Mean age (SD): 73.3 
(10.5) 
  
17. Moreno 
(2015) Colombia 
102 carers NR 
3.9 
Diagnosis: NR SF-36 Physical 
functioning, Role-
Physical, Vitality, 
Social functioning, 
Bodily pain and 
General Health  
components 
Satisfaction with life; Depression (PHQ-9); Burden (ZBI) 
Female %: 81.4  Severity: NR 
Mean age (SD): 58.4 
(13.3) 
  
   
      
18. 
Nogueira 
(2015) 
Brazil 
54 carers Spouse: 100 
NR 
Diagnosis: 
Alzheimer's  
QoL-AD PwD QoL (QoL-AD); Burden (ZBI); PWD functional status; PwD awareness of disease 
Female %: 66.7  Moderate: 62.96 
Mean age (SD): Males: 72 
(13.6); Females:67.6 (8.2) 
 Severe: 37.04 
  
19. Novelli 
(2010) Brazil 
60 carers Spouse: 41.67 
NR 
Diagnosis: 
Alzheimer's  
QoL-AD (mild 
dementia and 
moderate dementia) 
PwD cognitive function; PwD depression/mood; PwD 
Insturmental ADL; PwD ADL; PwD behavioral 
disturbances (NPI); Carer depression/mood (GDS); PwD 
QoL self-reported; Carer-rated PwD QoL (QoL-AD) 
Female %: 73.3 Daughter/son: 41.67 Mild: 50.0 
Mean age (SD): Sibilings: 13.33 Moderate: 50.0 
Mild dementia: 59.5 
(15.4) Other: 3.3 
 
Moderate: 60.1(14.5)   
20. 
Papastavrou 
(2014) 
Cyprus 
 76 carers Spouse: 53.0  Diagnosis: NR 
QoL-AD Burden (ZBI); Depression (CES-D); ADL 
Female %: 75.0 Other:47.0 1-2: 33.3 Severity: NR 
Age%:  <50: 18.0; 51-60: 
25.0; 61-70: 29.0; >71: 
21.0 
 3-4: 28  
 >5: 38.7  
21. Perrin 
(2014) Colombia 
90 carers Spouse: 17.8 
3.7 
Alzheimer's: 91.11 
SF-36 (Values not 
available to conduct 
meta-analysis) 
Satisfaction with life; Depression (PHQ-9); Burden (ZBI) 
Female %: 64.4 Daughter/son: 22.2 Vascular: 4.44 
Mean age (SD): 54.1 
(11.5) Sibilings: 60.0 Mixed: 2.22 
    Others: 2.22 
Note:NR= Not reported; QoL= quality of life; PwD= people with dementia; AD= Alzheimer’s Disease. SF= Short form; ZBI= Zarit Burden Interview; PHQ-9= Patient health questionnaire; ADL= Activities of daily living; IADL= Instrumental 
activities of daily living; CES-D= Center for Epidemiologic Studies Depression Scale. Variables in bold are those ones that presented statistically significant correlations with carer QoL. 
Authors Country Sample Relationship to patient (%) 
Average 
length being 
carer in years 
Care Recipient 
Characteristics 
(Diagnosis, 
severity %) 
Carer QoL 
measures Variables correlated with QoL 
22. Santos 
(2014) Brazil 
88 carers Spouse: 31.8 4.4 
Diagnosis: 
Alzheimer's  
QoL-AD 
Carer's gender; Carer's age; Carer's schooling; Burden 
(ZBI); Mood (BDI); Anxiety; PwD gender; PwD age; 
PwD schooling; PwD marital status; PwD age of onset; 
PwD duration of disease; PwD self-rated QoL (QoL-
AD); PwD carer-rated (QoL-AD); PwD cognition; PwD 
depression; PwD funtional activities; PwD 
Neuropsychiatric symptoms (NPI)   
Female %: 76.1 Daughter/son: 48.9  Mild: 48.9 
Mean age (SD): 59.22 
(13.8) Other: 19.3  
Moderate: 51.1 
    
    
    
23. 
Schiffczyk 
(2013) 
Germany 
194 carers NR 
NR 
Diagnosis: 
Alzheimer's  
QoL-AD PwD cognitive symptoms; Non-cognitive symptoms of the PwD (Behave-AD) Female %: 72.2  (most of them) 
Mean age (SD): 69 (7.7)   Severity: NR 
24. 
Scholzel-
Dorenbos 
(2009) 
The 
Netherlands 
87 carers NR 
NR 
Diagnosis: 
Alzheimer's  
SEIQoL PwD cognitive symptoms; Burden (ZBI) Female %: 47.0  Severity: NR 
Mean age (SD): 72.2 (7.3)     
25. Shin 
(2005) 
United 
States 
62 carers Spouse: 51.6 
NR 
Diagnosis: 
Alzheimer's  
QoL-AD PwD Neuropsychiatric symptoms (NPI); Caregiver distress Female %: NR Daughter/son: 33.9 Severity: NR 
Mean age (SD):NR Other: 14.5   
26. 
Takahashi 
(2005) 
Japan 
23 carers Spouse: 78.3 
3 
Alzheimer's: 73.9 
WHO-QOL26 Depression 
Female %: 78.27 Daughter/son: 60.9 Vascular: 4.3 
Mean age (SD): 61.1 
(13.0) Other: 17.4 Lewy bodies: 8.7 
  Frontotemporal: 8.7 
  Others: 4.4 
  Mild: 30.4 
  Moderate: 30.4 
    Severe: 3.1 
27. Takai 
(2011) Japan 
118 carers Spouse: 55.1 
NR 
Alzheimer's: 77.9 
WHO-QOL26 
PwD Cognitive function; PwD Cognitive and functional 
performance; PwD Neuropsychiatric symptoms (NPI); 
Burnout; Depression (BDI-II) 
Female %: 59.3 Daughter/son: 37.3 Vascular: 11.0 
Mean age (SD): 60.9 
(14.0) Other: 7.6 Lewy bodies: 2.5 
  Frontotemporal: 4.2 
  Mixed: 4.2 
    Severity: NR 
Note:NR= Not reported; QoL= quality of life; PwD= people with dementia AD= Alzheimer’s Disease;. ZBI= Zarit Burden Interview; BDI= Bender Depression Inventory; NPI= Neuropsychiatric Inventory. Variables in bold are those ones that 
presented statistically significant correlations with carer QoL. 
  
Authors Country Sample Relationship to patient (%) 
Average 
length 
being 
carer in 
years 
Care Recipient 
Characteristics 
(Diagnosis, 
severity %) 
Carer QoL 
measures Variables correlated with QoL 
28. Tay 
(2016) Singapore 
84 carers Spouse: 7.1 
NR 
Alzheimer's: 36.9 
WHOQoL-BREF  
Family burden (FBIS); Coping strategies Total; General 
perceived self-efficacy; Caregiver's age; Patient's age; 
Income 
Female %: 69.0 Daughter/son: 83.3 Vascular: 27.4 
Mean age (SD): 50.89 
(10.6) Other: 9.6 Mixed: 35.7 
  Mild: 59.5 
  Moderate: 40.5 
29. 
Thompson 
(2004) 
United 
States 
61 carers Spouse: 100 
5.3 
Diagnosis: 
Alzheimer's  
SF-36 (Mental 
component) 
Natural killer cell number; Male Sense of coherence; Male 
Depression (CES-D); Male Stress; Female Sense of 
coherence; Female Depression (CES-D); Female Stress 
Female %: 73.80  Severity: NR 
Mean age:   
Female: 69.7   
Male: 71.4   
30. 
Valimaki 
(2009) 
Finland 
170 carers Spouse: 100 
NR 
Diagnosis: 
Alzheimer's  
15D + 15D VAS 
PwD Cognitive function; PwD Neuropsychiatric symptoms 
(NPI); PwD Cognitive function; Caregiver's age; PwD age; 
HRQoL VAS; Sense of Coherence; Distress; Depression 
(BDI); Income; Total amount of medication; Years of 
education 
Female %: 62.9  Severity: Only Mild 
Mean age (SD): 71.6 (7.2)   
   
31. Vargas 
Escobar 
(2010) 
Colombia 
192 carers 
Daughter/son: most of 
them NR, 
between 
10-36 
months 
Diagnosis: 
Alzheimer's  
QOL (Betty Ferrell) PwD functional dependency 
Gender: most of them 
women  
Mild: 25.5 
Age: 36-59 years old  Moderate: 45.8 
    Severe: 28.6 
32. 
Weisman 
de Mamani 
(2017) 
United 
States 
106 carers Spouse: 14.2 
NR 
Diagnosis: 
Alzheimer's  
Quality of Life 
Inventory (QOLI) 
Expressed Emotion (EE) total; EE Emotional 
Overinvolvement; EE Criticism 
Female %: 81.1 Daughter/son: 51.9 Severity: NR 
Mean age (SD): 50.73 
(12.7) Sibilings: 1.9  
  Other: 32.1   
33. 
Zawadzki 
(2011) 
France 
51 carers Spouse: 57.0 3.5 
Diagnosis: 
Alzheimer's  
PIXEL Study 
Authoritarianism; Benevolence; Social restrictiveness; 
Community mental health ideology; Emotional Reaction 
Rejection; Emotional Reaction Anxiety; Emotional 
Reaction Agressiveness; Emotional Reaction Prosocial 
Reactions; Perceived overall incompetence; Perceived 
susceptibility of having AD during one day 
Female %: 66.67 Daughter/son: 37.0  Severity: NR 
Mean age (SD) Sibilings: 2.0  
 
Female: 64.3(10.2) Other: 10.0  
 
Male: 74.5(14.7)    
Note:NR= Not reported; QoL= quality of life; PwD= people with dementia AD= Alzheimer’s Disease; FBIS= Family Burden Interview Schedule; CES-D= Center for Epidemiologic Studies Depression Scale; NPI= Neuropsychiatric Inventory; 
HRQoL VAS= Visual analogue rating scale of health-related quality of life  BDI= Bender Depression Inventory;. Variables in bold are those ones that presented statistically significant correlations with carer QoL. 
  
Table 2: Assessment of study quality using the Appraisal of Cross-sectional Studies tool. 
  Study number according to table 1 
Introduction 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 
Were the aims/objectives of the study clear? Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
Was the study design appropriate for the stated aim(s)?  Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
Was the sample size justified?  Y N N N N N Y N N Y Y Y N N N Y N N N N Y N N N N N N Y N N N N N 
Was the target/reference population clearly defined? (Is 
it clear who the research was about?) Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
Was the sample frame taken from an appropriate 
population base so that it closely represented the target/ 
reference population under investigation?  
Y Y N Y Y N Y Y Y Y Y Y Y N N Y Y Y Y Y Y Y Y Y Y N N Y Y Y Y Y N 
Was the selection process likely to select 
subjects/participants that were representative of the 
target/reference population under investigation?  
Y Y N N N Y Y Y Y Y Y Y Y Y Y Y N N N Y N N N Y Y N Y N Y Y N Y Y 
Were measures undertaken to address and categorise 
non-responders?  Y N N Y Y N Y N Y Y N N N Y Y Y N N N Y Y N Y Y N N Y N N N N N N 
Were the risk factor and outcome variables measured 
appropriate to the aims of the study?  Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
Were the risk factor and outcome variables measured 
correctly using instruments/ measurements that had been 
trialled, piloted or published previously?  
Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
Is it clear what was used to determined statistical 
significance and/or precision estimates? (e.g. p-values, 
confidence intervals)  
Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
Were the methods (including statistical methods) 
sufficiently described to enable them to be repeated? Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
Note: Y= Yes, (the study clearly demonstrated the information regarding the question); N= No, (no clear information was provided in the study to record the item as yes)  
  Study number according to table 1 
Results 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 
Were the basic data adequately described?  Y Y Y Y Y Y Y Y Y Y Y N Y N Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y N Y Y 
Does the response rate raise concerns 
about non-response bias? Y N N Y Y N Y N Y N N N N Y Y Y N N N Y N N Y Y N N Y N N N N N N 
If appropriate, was information about non-
responders described? N N N N N N Y N N N N N N N N N N N N N N N N N N N N N N N N N N 
Were the results internally consistent? Y Y Y Y Y Y Y Y Y Y Y N Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
Were the results presented for all the 
analyses described in the methods? Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
Discussions                                  
Were the authors' discussions and 
conclusions justified by the results? Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y N Y Y Y Y Y Y Y Y Y Y 
Were the limitations of the study 
discussed? Y N Y Y Y Y Y N Y Y Y Y Y Y Y Y Y Y Y Y Y Y N Y Y N Y Y N N N Y Y 
Other                                  
Were there any funding sources or 
conflicts of interest that may affect the 
authors’ interpretation of the results?  
Y N N Y N Y Y Y Y Y N Y N N N N N Y Y Y Y N Y N Y N Y Y N Y Y N Y 
Was ethical approval or consent of 
participants attained? Y Y Y N Y Y Y Y Y Y N Y N N Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y N 
Total number of items rated as yes 19 14 13 16 16 15 20 15 18 18 15 15 14 14 16 18 14 15 15 18 17 14 15 17 16 12 17 16 14 15 13 15 14 
Note: Y= Yes, (the study clearly demonstrated the information regarding the question); N= No, (no clear information was provided in the study to record the item as yes)
Figure 2: Forest plot for independent variables with a significant effect. 
 
  
 
 
 
 
 
  
Supplementary table 1: PRISMA checklist. 
 # Checklist item  Reported on page #  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  1 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, 
participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and 
implications of key findings; systematic review registration number.  
3 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  4–6 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, 
outcomes, and study design (PICOS).  
7 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide 
registration information including registration number.  
8 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, 
language, publication status) used as criteria for eligibility, giving rationale.  
8 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify 
additional studies) in the search and date last searched.  
8 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it could be 
repeated.  
8 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, 
included in the meta-analysis).  
9 
Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes 
for obtaining and confirming data from investigators.  
9 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and 
simplifications made.  
9 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was 
done at the study or outcome level), and how this information is to be used in any data synthesis.  
10 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).  10-11 
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of consistency 
(e.g., I2) for each meta-analysis.  
10-11 
 Section/topic  # Checklist item  Reported on page #  
Risk of bias across studies  15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective 
reporting within studies).  
11 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating 
which were pre-specified.  
12 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at 
each stage, ideally with a flow diagram.  
12 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and 
provide the citations.  
13-14 
Risk of bias within studies  19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).  14 
Results of individual studies  20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
14 
Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and measures of consistency.  14-16 
Risk of bias across studies  22 Present results of any assessment of risk of bias across studies (see Item 15).  16-17 
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]).  17-18 
DISCUSSION   
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to 
key groups (e.g., healthcare providers, users, and policy makers).  
18-19 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of 
identified research, reporting bias).  
19-21 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for future research.  21-22 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the 
systematic review.  
2 
 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. 
doi:10.1371/journal.pmed1000097  
  
Supplementary table 2: Search strategy. 
Search terms              
#1 demen*    #8 "quality of life"    #19 informal*  
#2 alzheimer*    #9 QOL    #20 unpaid  
#3 (#1 OR #2)    #10 QL    #21 spous*  
#4 carer*    #11 HRQOL    #22 espos*  
#5 caregiver*    #12 HRQL    #23 famil*  
#6 cuidador*    #13 "calidad de vida"    #24 (#19 OR #20 OR #21 OR #22 OR #23)  
#7 (#4 OR #5 OR #6)     #14 "qualidade de vida"    #25 (#3 AND #7 AND #18 AND #24)  
    #15 wellbeing      
    #16 bienestar      
    #17 "bem-estar"      
    #18 (#8 OR #9 OR #10 OR #11 OR #12 OR       
      #13 OR #14 OR #15 OR #16 OR #17)        
 
  
Supplementary Figure 1: Forest plot for independent variables with non-significant effect. 
 
 
 
 
  
 
 
 
 
 
